Topic Review
Two-Faced Role of TANs in Tumor Progression
Tumor-associated neutrophils (TANs) may differentiate into different patterns under the stimulation of different factors, and they play a dual role in the occurrence and progression of tumors in direct or indirect ways.
  • 534
  • 25 Nov 2022
Topic Review
Host Defense Peptides
Host defense peptides (HDPs), also known as antimicrobial peptides, are an important component of the innate immune system. HDPs possess both antimicrobial and immunomodulatory properties. HDPs and their derivatives are being actively explored for antimicrobial therapies. A host-directed approach to stimulate the synthesis of endogenous HDPs is also being developed to treat infections with a minimum risk for developing antimicrobial resistance.
  • 533
  • 18 Apr 2023
Topic Review
Dendritic Cell-Based Cancer Immunotherapy
Cancer immunotherapy has now attracted much attention because of the recent success of immune checkpoint inhibitors. However, they are only beneficial in a limited fraction of patients most probably due to lack of sufficient CD8+ cytotoxic T-lymphocytes against tumor antigens in the host. In this regard, dendritic cells are useful tools to induce host immune responses against exogenous antigens. In particular, recently characterized cross-presenting dendritic cells are capable of inducing CD8+ cytotoxic T-lymphocytes against exogenous antigens such as tumor antigens and uniquely express the chemokine receptor XCR1. 
  • 532
  • 29 Jul 2021
Topic Review
CD83 as Checkpoint Molecule Controlling Resolution of Inflammation
Chronic inflammatory diseases and transplant rejection represent major challenges for modern health care. Thus, identification of immune checkpoints that contribute to resolution of inflammation is key to developing novel therapeutic agents for those conditions. In recent years, the CD83 (cluster of differentiation 83) protein has emerged as an interesting potential candidate for such a “pro-resolution” therapy. This molecule occurs in a membrane-bound and a soluble isoform (mCD83 and sCD83, respectively), both of which are involved in resolution of inflammation. Originally described as a maturation marker on dendritic cells (DCs), mCD83 is also expressed by activated B and T cells as well as regulatory T cells (Tregs) and controls turnover of MHC II molecules in the thymus, and thereby positive selection of CD4+ T cells. Additionally, it serves to confine overshooting (auto-)immune responses. Consequently, animals with a conditional deletion of CD83 in DCs or regulatory T cells suffer from impaired resolution of inflammation. Pro-resolving effects of sCD83 became evident in pre-clinical autoimmune and transplantation models, where application of sCD83 reduced disease symptoms and enhanced allograft survival, respectively.
  • 532
  • 07 Feb 2022
Topic Review
Gut Microbiota and Immunotherapy
Gut microbiota can have opposing functions from pro-tumorigenic to anti-tumorigenic effects. Increasing preclinical and clinical evidence suggests that the intestinal microbiota affects cancer patients’ response to immune checkpoint inhibitors (ICIs) immunotherapy, such as anti-programmed cell death protein 1 (PD-1) and its ligand (PD-L1) and anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4). Microbiota-induced inflammation possibly contributes to tumor growth and cancer development. Microbiota-derived metabolites can also be converted to carcinogenic agents related to genetic mutations and DNA damage in organs such as the colon. However, other attributes of microbiota, such as greater diversity and specific bacterial species and their metabolites, are linked to better clinical outcomes and potentially improved anti-tumor immunity. In addition, the intratumoral microbial composition strongly affects T-cell-mediated cytotoxicity and anti-tumor immune surveillance, adding more complexity to the cancer-microbiome-immune axis.
  • 532
  • 26 Aug 2022
Topic Review
Pathophysiological Hypoxia Shapes Immune Response
Oxygen availability varies throughout the human body in health and disease. Under physiological conditions, oxygen availability drops from the lungs over the blood stream towards the different tissues into the cells and the mitochondrial cavities leading to physiological low oxygen conditions or physiological hypoxia in all organs including primary lymphoid organs. Moreover, immune cells travel throughout the body searching for damaged cells and foreign antigens facing a variety of oxygen levels.
  • 529
  • 09 Jun 2021
Topic Review
Immunotherapy of Pancreatic Cancer
Immunotherapy is a novel anti-cancer method which employs a different mechanism to conventional treatment. It has become a significant strategy because it provides a better or an alternative option for cancer patients. The development of immunotherapy should focus on the discovery of biomarkers to screen suitable patients, new targets on tumors, neoadjuvant immunotherapy and the combination of immunotherapy with conventional therapeutic methods. 
  • 529
  • 29 Mar 2022
Topic Review
Mass Spectrometry-Based Proteomics
Omics technologies provide the tools required to investigate DNA, RNA, proteins, and other molecular determinants. These technologies include genomics, transcriptomics, proteomics, and metabolomics. However, proteomics is one of the main approaches to studying allergic disorders’ pathophysiology. Proteins are used to indicate normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Proteomics studies the complete set of proteins present in a live organism at a specific time or condition, including expression, structure, functions, interactions, and modifications, which are crucial for early disease diagnosis, prognosis, and monitoring of disease development.
  • 529
  • 26 May 2022
Topic Review
Macrophages and Wnts in Tissue Injury and Repair
Macrophages, one of the body’s most abundant populations of leukocytes, are mainly derived from the yolk sac during embryogenesis and are found in almost every tissue that plays an essential role during mammalian development. They are specialized phagocytes, large vacuolated cells with abundant cytoplasm containing lysosomal granules. Wnt signaling is a conserved pathway across species. It is involved in various essential tasks by regulating cell differentiation, proliferation, stem cell development, immune cell functions, and tissue repair. Evidence for the Wnt system’s pivotal role is that aberrant alterations of this molecular pathway are involved in multiple human disorders and pathologies, such as congenital abnormalities, autoimmune diseases, and cancer. Wnt and macrophages in the most immunologically active lung, liver, intestine, kidney, heart, and skin are discussed.
  • 529
  • 26 Dec 2022
Topic Review
Dysregulated Immune Response after Burn Injury
Burn injury induces a complex inflammatory response, both locally and systemically, and is not yet completely unravelled and understood. In order to enable the development of accurate treatment options, it is of paramount importance to fully understand post-burn immunology. Persistent activity of complement, acute phase proteins and pro- and anti-inflammatory mediators, changes in lymphocyte activity, activation of the stress response and infiltration of immune cells have all been related to post-burn local and systemic pathology.
  • 529
  • 08 Feb 2023
Topic Review
Inflammation
Inflammation, a vital and intricately regulated biological response, defends the body against threats like pathogens and injuries. When balanced, it supports health, but disruption can lead to chronic inflammation and diseases like cardiovascular issues and cancer. This exploration delves into inflammation's mechanisms, involving lipid-derived mediators, proinflammatory cytokines, vasoactive mediators, hydrolytic enzymes, reactive oxygen species, transcription factors, and the complement system. Understanding these elements is crucial for targeted therapies against inflammation-related diseases. Researchers continually uncover innovative strategies to restore the balance between protective and pathological inflammation, offering hope to millions with chronic inflammatory conditions. Advancements promise more effective management, a brighter future, and improved lives.
  • 529
  • 08 Sep 2023
Topic Review
Metabolism in Chimeric Antigen Receptor T Cells
The manufacture of efficacious chimeric antigen receptor (CAR) T cells represents a major challenge in cellular therapy. An important aspect of their quality concerns energy production and consumption, known as metabolism. T cells tend to adopt diverse metabolic profiles depending on their differentiation state and their stimulation level. It is therefore expected that the introduction of a synthetic molecule such as CAR, activating endogenous signaling pathways, will affect metabolism. In addition, upon patient treatment, the tumor microenvironment might influence the CAR T cell metabolism by compromising the energy resources. The access to novel technology with higher throughput and reduced cost has led to an increased interest in studying metabolism. Indeed, methods to quantify glycolysis and mitochondrial respiration have been available for decades but were rarely applied in the context of CAR T cell therapy before the release of the Seahorse XF apparatus. 
  • 528
  • 13 May 2022
Topic Review
Diet, Inflammation & Youth
In children and adolescents, chronic low-grade inflammation has been implicated in the pathogenesis of co- and multi-morbid conditions to mental health disorders. Diet quality is a potential mechanism of action that can exacerbate or ameliorate low-grade inflammation. A good quality diet, high in vegetable and fruit intake, wholegrains, fibre and healthy fats ameliorates low-grade inflammation, and therefore represents a promising therapeutic approach, as well as an important element for disease prevention in both children and adolescents.
  • 526
  • 11 Mar 2021
Topic Review
Tumor Necrosis Factor Receptor 2 in Colorectal Cancer
Colorectal cancer (CRC) represents one of the most common causes of death among cancers worldwide. Its incidence has been increasing among the young population. Many risk factors contribute to the development and progression of CRC and about 70% of them are sporadic. The CRC microenvironment is highly heterogeneous and represents a very complex immunosuppressive platform. Many cytokines and their receptors are vital participants in this immunosuppressive microenvironment. Tumor necrosis factors (TNFs) and TNF receptor 2 (TNFR2) are critical players in the development of CRC. TNFR2 was observed to have increased the immunosuppressive activity of CRC cells via regulatory T cells (T regs) and myeloid-derived suppressor cells (MDSC) in the CRC microenvironment.
  • 526
  • 07 Feb 2023
Topic Review
Viral Infections in Severe Asthma
Viral respiratory infections are recognized risk factors for the loss of control of allergic asthma and the induction of exacerbations. Severe asthma is more susceptible to virus-induced asthma exacerbations, especially in the presence of high IgE levels.
  • 525
  • 22 May 2021
Topic Review
Regulation of Class Switch Recombination by G4 Structures
Mature B cells notably diversify immunoglobulin (Ig) production through class switch recombination (CSR), allowing the junction of distant “switch” (S) regions. CSR is initiated by activation-induced deaminase (AID), which targets cytosines adequately exposed within single-stranded DNA of transcribed targeted S regions, with a specific affinity for WRCY motifs. In mammalian S regions, abundant G4 (G-quadruplex) DNA on the non-template strand also contributes to the formation of R-loops while the presence of G4 structures within the primary transcripts from S regions participates into recruiting AID. The ability of G4 ligands to modulate the CSR process also underlines the key role of G4 structures in the regulation of CSR.
  • 524
  • 03 Feb 2023
Topic Review
CAR-Based Therapy for Autoimmune and Immune-Mediated Diseases
The pervasive application of chimeric antigen receptor (CAR)-based cellular therapies in the treatment of oncological diseases has long been recognized. However, CAR T cells can target and eliminate autoreactive cells in autoimmune and immune-mediated diseases. By doing so, they can contribute to an effective and relatively long-lasting remission. In turn, CAR Treg interventions may have a highly effective and durable immunomodulatory effect via a direct or bystander effect, which may have a positive impact on the course and prognosis of autoimmune diseases. CAR-based cellular techniques have a complex theoretical foundation and are difficult to implement in practice, but they have a remarkable capacity to suppress the destructive functions of the immune system.
  • 523
  • 07 Jun 2023
Topic Review
Specialized Pro-Resolving Lipid Mediators
Resolvins (Rvs), Maresins (MaRs), Protectins (PDs), and Lipoxins (LXs), belong to a large group of molecules known as The Specialized Pro-resolving Lipid Mediators (SPMs). These compounds have been well-characterized since their identification as potent modulators of the immune response and for their effects on inflammation resolution. Furthermore, they have a potential effect on anti-tumor immunity.
  • 523
  • 17 Aug 2023
Topic Review
Caspase-1 Inhibition
The inflammatory protease caspase-1 is associated with the release of cytokines. An excessive number of cytokines (a “cytokine storm”) is a dangerous consequence of COVID-19 infection and has been indicated as being among the causes of death by COVID-19. The anti-inflammatory drug colchicine (which is reported in the literature to be a caspase-1 inhibitor) and the corticosteroid drugs, dexamethasone and methylprednisolone, are among the most effective active compounds for COVID-19 treatment.
  • 522
  • 18 Feb 2022
Topic Review
Nanomedicine for Immune Escape in Breast Cancer
Nanomedicine has gained great importance in cancer immunotherapy, as many emerging nanoplatforms with different designs have been recently developed to overcome various mechanisms of cancer immune escape and increase the efficacy of antitumor immune response.
  • 521
  • 11 Mar 2022
  • Page
  • of
  • 39
ScholarVision Creations